Penn Capital Management Company, LLC

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1158202 PHILADELPHIA, PA

Position in MIRM

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$23,720,135

+$1,451,433 QoQ

Shares Held

256,767

-8.9% QoQ

Ownership

0.421%

of shares outstanding

% of Portfolio

1.85%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Penn Capital Management Company, LLC holds $79,843,281 across 7 Biotechnology names. MIRM ranks #1 (29.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc. This page	256,767	$23,720,135
2	LGND	Ligand Pharmaceuticals Inc	95,456	$19,057,790
3	TGTX	Tg Therapeutics, Inc.	541,960	$18,003,911
4	SLNO	Soleno Therapeutics Inc	268,785	$8,998,921
5	ARQT	Arcutis Biotherapeutics, Inc.	333,130	$7,848,542
6	MDGL	Madrigal Pharmaceuticals, Inc.	3,510	$1,837,379
7	TVTX	Travere Therapeutics, Inc.	12,676	$376,603

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,720,135	256,767	-8.9%	Shares	Sole	2026-05-07
2025-12-31	$22,268,702	281,918	-8.5%	Shares	Sole	2026-02-09
2025-09-30	$22,578,820	307,991	-10.0%	Shares	Sole	2025-11-24
2025-06-30	$17,417,407	342,256	-8.4%	Shares	Sole	2025-08-14
2025-03-31	$16,827,030	373,519	+34.2%	Shares	Sole	2025-05-14
2024-12-31	$11,512,956	278,427	-10.0%	Shares	Sole	2025-02-14
2024-09-30	$12,060,516	309,244	+28.2%	Shares	Sole	2024-11-14
2024-06-30	$8,244,952	241,151	-1.8%	Shares	Sole	2024-08-13
2024-03-31	$6,171,883	245,696	-0.0%	Shares	Sole	2024-05-15
2023-12-31	$7,253,890	245,728	-0.1%	Shares	Sole	2024-02-14
2023-09-30	$7,772,652	245,970	+2.8%	Shares	Sole	2023-11-15
2023-06-30	$6,190,018	239,274	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.